VolitionRX Ltd (VNRX)

Apr 24, 2026

VolitionRX | 8-K: Current report - Moomoo

Apr 24, 2026

Apr 24, 2026

VolitionRx receives NYSE American compliance plan approval By Investing.com - Investing.com Australia

Apr 24, 2026

Apr 23, 2026

VolitionRx Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Apr 23, 2026

Apr 23, 2026

VolitionRx (NYSE: VNRX) wins NYSE American time to fix listing - Stock Titan

Apr 23, 2026

Apr 23, 2026

VolitionRx shares stay on NYSE as exchange accepts compliance plan - Stock Titan

Apr 23, 2026

Apr 21, 2026

D Boral Capital downgrades VolitionRx (VNRX) - MSN

Apr 21, 2026

Apr 20, 2026

VolitionRx launches online shop for recombinant nucleosomes By Investing.com - Investing.com Australia

Apr 20, 2026

Apr 20, 2026

VNRX Downgraded by D. Boral Capital -- Rating Changed to Hold - GuruFocus

Apr 20, 2026

Apr 20, 2026

VolitionRx Ltd stock (US92852X1037): Does its blood-testing tech unlock real diagnostic upside? - AD HOC NEWS

Apr 20, 2026

Apr 20, 2026

D. Boral Capital downgrades VolitionRX stock rating on reverse split By Investing.com - Investing.com South Africa

Apr 20, 2026

Apr 20, 2026

D. Boral Capital Downgrades VolitionRX(VNRX.US) to Hold Rating - Moomoo

Apr 20, 2026

Apr 20, 2026

After building for 10 years, Volition puts nucleosomes up for sale online - Stock Titan

Apr 20, 2026

Apr 18, 2026

VolitionRx Limited Files Form 8-K With SEC Detailing Company Information and Compliance Data - Minichart

Apr 18, 2026

Apr 18, 2026

VolitionRx Ltd stock (US92852X1037): Is its blood-testing breakthrough strong enough to unlock inves - AD HOC NEWS

Apr 18, 2026

Apr 17, 2026

VolitionRx (VNRX) to execute 1-for-20 reverse stock split on April 28, 2026 - Stock Titan

Apr 17, 2026

Apr 17, 2026

VNRX Should I Buy - Intellectia AI

Apr 17, 2026

Apr 16, 2026

VNRX Stock Price, Quote & Chart | VOLITIONRX LTD (NYSEARCA:VNRX) - ChartMill

Apr 16, 2026

Apr 14, 2026

VolitionRx Ltd stock (US92852X1037): Why does its blood-testing innovation matter more now for U.S. - AD HOC NEWS

Apr 14, 2026

Apr 06, 2026

H.C. Wainwright cuts VolitionRX stock price target to $1 on share count - Investing.com Australia

Apr 06, 2026

Apr 04, 2026

VolitionRx Earnings Call: Breakthroughs Amid Funding Strain - TipRanks

Apr 04, 2026

Apr 04, 2026

VolitionRx Limited (VNRX) stock price, news, quote and history - Yahoo Finance UK

Apr 04, 2026

Apr 04, 2026

VNRX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 04, 2026

Apr 03, 2026

VolitionRX (VNRX) FY2025 Earnings: Q4 EPS and Revenue Not Disclo - GuruFocus

Apr 03, 2026

Apr 03, 2026

VolitionRX Is Maintained at Buy by HC Wainwright & Co. - Moomoo

Apr 03, 2026

Apr 03, 2026

VolitionRx Limited (AMEX:VNRX) Q4 2025 Earnings Call Transcript - Insider Monkey

Apr 03, 2026

Apr 03, 2026

VolitionRX Q4 Earnings Call Highlights - Defense World

Apr 03, 2026

Apr 02, 2026

VolitionRX Ltd (VNRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Apr 02, 2026

Apr 02, 2026

VolitionRX Ltd (VNRX) Q4 2025 Earnings Call Highlights: Strong R - GuruFocus

Apr 02, 2026

Apr 02, 2026

VolitionRx: Robust Revenue Growth and Promising Capture-Seq Data Support Buy Rating Despite Dilution-Driven Target Cut - TipRanks

Apr 02, 2026

Apr 02, 2026

VolitionRX (VNRX) Sees Target Price Cut Despite Maintained Buy R - GuruFocus

Apr 02, 2026

Apr 02, 2026

VolitionRx Limited (VNRX) 8-K SEC Filing March 31, 2026: Company Details, Address, and Stock Information - Minichart

Apr 02, 2026

Apr 01, 2026

VolitionRx (NYSE: VNRX) wins approval for major share issue and reverse split - Stock Titan

Apr 01, 2026

Apr 01, 2026

Earnings call transcript: VolitionRx Q4 2025 reveals mixed financial results By Investing.com - Investing.com South Africa

Apr 01, 2026

Apr 01, 2026

Earnings call transcript: VolitionRx Q4 2025 reveals mixed financial results - Investing.com

Apr 01, 2026

Apr 01, 2026

Q4 2025 VolitionRX Ltd Earnings Call Transcript - GuruFocus

Apr 01, 2026

Apr 01, 2026

VolitionRx : Corporate Presentation April 2026 - marketscreener.com

Apr 01, 2026

Apr 01, 2026

VolitionRX's Nu.Q Cancer Reimbursement Decision in Q4 2026 Could Unlock Commercial Licensing Momentum Amid Dilution Risks - Bitget

Apr 01, 2026

Apr 01, 2026

VolitionRx secures €2M in Belgian government financing By Investing.com - Investing.com South Africa

Apr 01, 2026

Apr 01, 2026

Volitionrx Ltd earnings beat, revenue fell short of estimates By Investing.com - Investing.com India

Apr 01, 2026

Apr 01, 2026

Volitionrx Ltd earnings beat, revenue fell short of estimates - Investing.com UK

Apr 01, 2026

Apr 01, 2026

VolitionRX Q4 2025 Earnings Call Transcript - MarketBeat

Apr 01, 2026

Apr 01, 2026

VolitionRX: Q4 Earnings Snapshot - theheraldreview.com

Apr 01, 2026

Mar 31, 2026

VolitionRX (VNRX) Rating Maintained as Buy by D. Boral Capital | - GuruFocus

Mar 31, 2026

Mar 31, 2026

VolitionRx (NYSE: VNRX) details going concern risk, funding needs and Nu.Q® rollout - Stock Titan

Mar 31, 2026

Mar 31, 2026

Volition says its tests are nearing hospital use in lung cancer and sepsis - Stock Titan

Mar 31, 2026

Mar 31, 2026

VolitionRX Price Target Maintained With a $3.00/Share by D. Boral Capital - Moomoo

Mar 31, 2026

Mar 31, 2026

VolitionRX Ltd (VNRX) Q4 2025: Everything You Need to Know Ahead of Earnings - GuruFocus

Mar 31, 2026